- Home
- RMBS vs ITGR Comparison
RMBS vs ITGR Comparison
Compare RMBS & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMBS
- ITGR
- Stock Information
- Founded
- RMBS 1990
- ITGR 1970
- Country
- RMBS United States
- ITGR United States
- Employees
- RMBS N/A
- ITGR N/A
- Industry
- RMBS Semiconductors
- ITGR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- RMBS Technology
- ITGR Health Care
- Exchange
- RMBS Nasdaq
- ITGR Nasdaq
- Market Cap
- RMBS N/A
- ITGR 4.2B
- IPO Year
- RMBS 1997
- ITGR 2000
- Fundamental
- Price
- RMBS $64.76
- ITGR $117.46
- Analyst Decision
- RMBS Strong Buy
- ITGR Strong Buy
- Analyst Count
- RMBS 4
- ITGR 10
- Target Price
- RMBS $78.25
- ITGR $145.90
- AVG Volume (30 Days)
- RMBS 841.5K
- ITGR 417.4K
- Earning Date
- RMBS 07-28-2025
- ITGR 07-24-2025
- Dividend Yield
- RMBS N/A
- ITGR N/A
- EPS Growth
- RMBS N/A
- ITGR N/A
- EPS
- RMBS 1.91
- ITGR 2.18
- Revenue
- RMBS $605,417,000.00
- ITGR $1,746,192,000.00
- Revenue This Year
- RMBS $26.64
- ITGR $11.03
- Revenue Next Year
- RMBS $13.11
- ITGR $7.29
- P/E Ratio
- RMBS $33.67
- ITGR $54.21
- Revenue Growth
- RMBS 30.13
- ITGR 10.19
- 52 Week Low
- RMBS $37.43
- ITGR $104.93
- 52 Week High
- RMBS $69.15
- ITGR $146.36
- Technical
- Relative Strength Index (RSI)
- RMBS 61.54
- ITGR 42.39
- Support Level
- RMBS $61.16
- ITGR $116.25
- Resistance Level
- RMBS $65.76
- ITGR $122.99
- Average True Range (ATR)
- RMBS 1.65
- ITGR 2.41
- MACD
- RMBS -0.25
- ITGR -0.24
- Stochastic Oscillator
- RMBS 70.04
- ITGR 16.07
About ITGR Integer Holdings Corporation
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.